Cargando…

Phosphorylated Hsp27 is mutually exclusive with ATRX loss and the IDH1(R132H) mutation and may predict better prognosis among glioblastomas without the IDH1 mutation and ATRX loss

AIM: To identify biomarkers for accurate classification of glioma. PATIENTS AND METHODS: We evaluated the heat shock protein 27 (Hsp27), phosphorylated Hsp27 (p-Hsp27), ATRX and IDH1(R132H)proteins using immunohistochemistry in 421 glioma tissues. The χ(2) test was used to assess the relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Hong-Qing, Wang, Peng-Fei, Zhang, Hai-Peng, Cheng, Zhi-Jian, Li, Shou-Wei, He, Jie, Zhang, Yu, Hao, Jia-Jie, Wang, Ming-Rong, Yan, Chang-Xiang, Wan, Jing-Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204978/ https://www.ncbi.nlm.nih.gov/pubmed/29550762 http://dx.doi.org/10.1136/jclinpath-2018-205000

Ejemplares similares

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas
por: Cai, Jinquan, et al.
Publicado: (2016)

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
por: Jiao, Yuchen, et al.
Publicado: (2012)

ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors
por: Cai, Jinquan, et al.
Publicado: (2016)

Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss
por: Li, Xia, et al.
Publicado: (2017)

ATRX regulates glial identity and the tumor microenvironment in IDH-mutant glioma
por: Babikir, Husam, et al.
Publicado: (2021)

Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival
por: Chaurasia, Ajay, et al.
Publicado: (2016)

IDH1, ATRX, and BRAFV600E mutation in astrocytic tumors and their significance in patient outcome in north Indian population
por: Chatterjee, Debajyoti, et al.
Publicado: (2018)

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma Patients
por: Priambada, Dody, et al.
Publicado: (2023)

The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
por: Grandin, Nathalie, et al.
Publicado: (2019)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
por: Udugama, Maheshi, et al.
Publicado: (2018)

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
por: Tesileanu, C. Mircea S., et al.
Publicado: (2021)

Significance of TERT and ATRX mutations in glioma
por: Liu, Jiayu, et al.
Publicado: (2019)

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
por: Cantero, Diana, et al.
Publicado: (2020)

The prognostic IDH1(R132) mutation is associated with reduced NADP(+)-dependent IDH activity in glioblastoma
por: Bleeker, Fonnet E., et al.
Publicado: (2010)

Loss of ATRX Does Not Confer Susceptibility to Osteoarthritis
por: Solomon, Lauren A., et al.
Publicado: (2013)

ATRX Loss in the Development and Prognosis of Conjunctival Melanoma
por: van Ipenburg, Jolique A., et al.
Publicado: (2023)

Mutant IDH1 is required for IDH1 mutated tumor cell growth
por: Jin, Genglin, et al.
Publicado: (2012)

IDH-1(R132H) mutation status in diffuse glioma patients: implications for classification
por: Wang, Peng-fei, et al.
Publicado: (2016)

MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Zeineldin, Maged, et al.
Publicado: (2020)

Loss of ATRX leads to chromosome cohesion and congression defects
por: Ritchie, Kieran, et al.
Publicado: (2008)

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study
por: Habiba, Umma, et al.
Publicado: (2021)

TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
por: de Nonneville, Alexandre, et al.
Publicado: (2022)

Characterisation of an Atrx Conditional Knockout Mouse Model: Atrx Loss Causes Endocrine Dysfunction Rather Than Pancreatic Neuroendocrine Tumour
por: Gaspar, Tiago Bordeira, et al.
Publicado: (2022)

Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

Loss of ATRX in Chondrocytes Has Minimal Effects on Skeletal Development
por: Solomon, Lauren A., et al.
Publicado: (2009)

Cellular and molecular mechanisms of neuronal loss in Atrx-knockout mice
por: Lagali, Pamela S, et al.
Publicado: (2013)

Capitalizing on ATRX loss in glioma via PARP inhibition: Comment on “Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity” by Garbarino et al.
por: Zalenski, Abigail A, et al.
Publicado: (2021)

Choroidal melanoma with synchronous Fuchs’ adenoma and novel ATRX mutation
por: Harford, Elli, et al.
Publicado: (2022)

Novel, clinically relevant genomic patterns identified by comprehensive genomic profiling in ATRX-deficient IDH-wildtype adult high-grade gliomas
por: Bedics, Gábor, et al.
Publicado: (2023)

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
por: Garbarino, Jennifer, et al.
Publicado: (2021)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

Disruption of ATRX-RNA interactions uncovers roles in ATRX localization and PRC2 function
por: Ren, Wenqing, et al.
Publicado: (2020)

IDH1 p.R132 mutations may not be actively involved in the carcinogenesis of hepatocellular carcinoma
por: Lu, Jun, et al.
Publicado: (2014)

Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype
por: Cuyàs, Elisabet, et al.
Publicado: (2015)

IDH1 R132C mutation is detected in clear cell hepatocellular carcinoma by pyrosequencing
por: Lee, Jung Hee, et al.
Publicado: (2017)

Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
por: Kaminska, Bozena, et al.
Publicado: (2019)

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine
por: Rowland, Megan E., et al.
Publicado: (2018)

IDH1 R132H Mutation Is Accompanied with Malignant Progression of Paired Primary-Recurrent Astrocytic Tumours
por: Mu, Luyan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_st2alprena1rmujihqddk1hl2o